Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Jun-24 8:21 PM View:  | Gossamer Bio, Inc. (GOSS) | 18-Jun-24 | Private Purchase | 100,000 | $0.59 | $59,110.00 | 26% 380.01K to 480.01K | |
| 28-Mar-24 6:05 PM View: | Gossamer Bio, Inc. (GOSS) | 27-Mar-24 | Sale | 6,430 | $1.16 | $7,430.51 | (1%) 479.18K to 472.75K | |
| 14-Nov-23 6:24 PM View: | Gossamer Bio, Inc. (GOSS) | 13-Nov-23 | Private Purchase | 200,000 | $0.56 | $112,880.00 | 72% 279.18K to 479.18K | |
| 26-Jul-23 4:03 PM View: | Gossamer Bio, Inc. (GOSS) | 24-Jul-23 | Grant | 54,020 | $1.82 | $98,316.40 | 28% 196.37K to 250.39K | |
| 05-Apr-23 4:26 PM View: | Gossamer Bio, Inc. (GOSS) | 04-Apr-23 | Private Purchase | 55,000 | $1.02 | $56,094.50 | 32% 170.16K to 225.16K | |
| 22-Mar-23 5:17 PM View: | Gossamer Bio, Inc. (GOSS) | 20-Mar-23 | Private Purchase | 50,000 | $0.97 | $48,435.00 | 42% 120.16K to 170.16K | |
| 15-Jul-22 4:23 PM View: | Gossamer Bio, Inc. (GOSS) | 15-Jul-22 | Private Purchase | 13,869 | $7.21 | $99,995.50 | 13% 106.29K to 120.16K | |
| 24-Mar-22 4:53 PM View: | Gossamer Bio, Inc. (GOSS) | 23-Mar-22 | Sale | 10,722 | $8.91 | $95,586.60 | (9%) 117.01K to 106.29K | |
| 25-Mar-21 4:11 PM View: | Gossamer Bio, Inc. (GOSS) | 23-Mar-21 | Market Sale | 5,490 | $9.48 | $52,045.70 | (4%) 122.5K to 117.01K | 8% |
| 01-Mar-21 4:50 PM View: | Gossamer Bio, Inc. (GOSS) | 25-Feb-21 | Grant | 45,000 | -- | -- | 58% 77.5K to 122.5K | |
| 14-Oct-20 7:27 PM View: | Gossamer Bio, Inc. (GOSS) | 14-Oct-20 | Market Purchase | 3,000 | $10.01 | $30,036.00 | 4% 74.5K to 77.5K | 3% |
| 23-Jun-20 5:01 PM View: | Gossamer Bio, Inc. (GOSS) | 23-Jun-20 | Market Purchase | 2,000 | $12.96 | $25,922.40 | 3% 72.5K to 74.5K | (20%) |
| 19-Feb-20 4:20 PM View: | Gossamer Bio, Inc. (GOSS) | 14-Feb-20 | Grant | 46,500 | -- | -- | 179% 26.0K to 72.5K | |
| 03-Dec-19 6:46 PM View: | Protagonist Therapeutics, Inc (PTGX) | 03-Dec-19 | Market Purchase | 8,000 | $5.70 | $45,620.00 | 80% 10.0K to 18.0K | 316% |
| 26-Sep-19 4:08 PM View: | Gossamer Bio, Inc. (GOSS) | 26-Sep-19 | Market Purchase | 1,121 | $16.78 | $18,810.20 | 5% 24.88K to 26.0K | (38%) |
| 03-Jun-19 4:03 PM View: | Gossamer Bio, Inc. (GOSS) | 30-May-19 | Market Purchase | 1,000 | $18.70 | $18,700.00 | 4% 23.88K to 24.88K | (45%) |
| 12-Feb-19 5:33 PM View: | Gossamer Bio, Inc. (GOSS) | 12-Feb-19 | Conversion | 17,879 | -- | -- | 100% 0 to 17.88K | |
| 12-Feb-19 5:33 PM View: | Gossamer Bio, Inc. (GOSS) | 12-Feb-19 | Purchase | 6,000 | $16.00 | $96,000.00 | 34% 17.88K to 23.88K | |
| 17-May-18 5:48 PM View: | Protagonist Therapeutics, Inc (PTGX) | 16-May-17 | Private Purchase | 10,000 | $6.46 | $64,566.00 | 100% 0 to 10.0K |